Three therapies, when used in combination, may slow advanced melanoma, according to a new study led by researchers at UCLA. The study, published online ahead of print in the journal Nature Medicine (June 6, 2019) showed that the combination of dabrafenib, trametinib, and pembrolizaumab can slow the growth of advanced melanoma cancer cells.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s